Vanguard Capital Management
NEPH icon

Vanguard Capital Management’s Nephros NEPH Stock Holding History

Vanguard Capital Management’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Hold
198,643
– – ﹤0.01% 3655
2026
Q1 		$592K Buy
+198,643
New +$793K ﹤0.01% 3643

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Vanguard Capital Management's NEPH Position: Q2 2026 in Review

Vanguard Capital Management held its Nephros (NEPH) position steady in Q2 2026 at 198,643 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #3655.

Vanguard Capital Management first reported a position in NEPH in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Vanguard Capital Management held 198,643 shares of Nephros worth $709K as of Q2 2026.
  • Vanguard Capital Management left its Nephros share count unchanged in Q2 2026.
  • Nephros made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3655 holding.
  • Vanguard Capital Management first reported a position in Nephros in Q1 2026 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.